Pharma company Zydus Cadila today received restricted Emergency use approval from India’s drug regulator for the use of Virafin, Pegylated Interferon alpha-2b (PegIFN) in treating moderate Covid-19 infection in adults. When administered early on during Covid, Virafin will help patients recover faster and avoid much of the complications, the company …
Read More »Russia’s Sputnik V gets Emergency Use authorisation nod in India, Health News, ET HealthWorld
New Delhi: Russia’s Sputnik V got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to get clearance in India. According to sources, the SEC approved Dr Reddy’s application for EUA to Sputnik V. The decision comes after the Drugs Controller …
Read More »